Acceptability, Feasibility, and Preliminary Effectiveness of a Mobile App for Teens With or at High Risk for Eating Disorders: A Three-Arm Pilot Randomized Controlled Trial Comparing Self-Help, Guided Self-Help, and Guided Self-Help With a Social Networking Component
Abstract
Objective: Given the wide treatment gap for eating disorders (EDs) and that these problems often emerge in adolescence, novel tools, such as app-based interventions, are needed to prevent and treat EDs in teens. However, questions remain about the optimal level of human support and features within these programs that could enhance outcomes (e.g., social networking). We conducted a pilot randomized controlled trial of a mobile app for teens with or at high risk for EDs, comparing self-help (control) to guided self-help (GSH) and GSH+ social networking (GSH+).
Method: N = 148 teens with or at high risk for EDs recruited from social media and an online EDs screen were randomized. Participants had access to their assigned intervention for 3 months and completed surveys at baseline, 6 weeks, 3 months, and 6 months.
Results: Teen qualitative feedback illustrated positive perceptions about acceptability and feasibility of the tool and its impact on ED-related thoughts and behaviors. There were no significant differences across groups for the main outcome, global ED psychopathology, but there was a significant reduction for all groups over time (ps < 0.01; d = -0.93 from baseline to 6 months). While all intervention conditions had significant reductions in binge eating behaviors over time, the rate of reduction was greatest in the GSH condition (p < 0.001).
Conclusions: Overall, our preliminary findings suggest that digital self-help interventions (both unguided and guided) may…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 148 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.